MedicalResearch.com Interview with:
Yana Vinogradova, PhD, Research Fellow
Division of Primary Care, School of Medicine
University of Nottingham
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Anticoagulants are prescribed for treatment and prevention of thrombosis and stroke but may lead to major bleeding. Unlike the older drug warfarin, newer direct oral anticoagulants do not require regular blood tests but their safety was shown only in selected patients and in trial conditions.
The study found that Direct Oral AntiCoagulants (DOACs) are safer than warfarin in terms of bleeding risks with apixaban being the safest.